These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 155750)

  • 21. [Thromboplastic, fibrinolytic and fibrinolysis-inhibitory activities of cultured human cancer cell lines (author's transl)].
    Naito S
    Fukuoka Igaku Zasshi; 1980 Apr; 71(4):207-20. PubMed ID: 7190116
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
    Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Effect of induced chronic intravascular coagulation on plasminogen activator in dogs.
    Owen CA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):309-11. PubMed ID: 1188714
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)].
    Saito K
    Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1443-51. PubMed ID: 4271707
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme].
    Plastonova TK; Petrenko OA
    Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some fibrinolytic properties of the human arteries and veins walls.
    Donner L; Vodáková L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):451-9. PubMed ID: 2431965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of various coagulation studies in the diagnosis of thromboses].
    Kuzin MI; Bokarev IN; Smolianitskiĭ AIa; Shumbalina LF; Dreĭzina AM
    Kardiologiia; 1974 Nov; 14(11):85-9. PubMed ID: 4279311
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].
    Soria J; Soria C; Samama M
    Pathol Biol (Paris); 1976 Dec; 24(10):725-9. PubMed ID: 138119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromogenic substrate assays of components of the fibrinolytic system.
    Lijnen HR; Collen D
    Acta Chir Scand Suppl; 1982; 509():129-32. PubMed ID: 6219528
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 33. [Abnormalities of coagulation and fibrinolysis in patients with neoplasms (author's transl)].
    Martínez Canaveri AA; Carreras LO; Abate NH; Taffuni de De Nigris M; Fustinoni O
    Sangre (Barc); 1977; 22(5):332-63. PubMed ID: 905936
    [No Abstract]   [Full Text] [Related]  

  • 34. [Somatostatin and the hemostatic system (author's transl)].
    Hnidec O
    Przegl Lek; 1980; 37(4):421-3. PubMed ID: 6105700
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of fibrinolysis (review of the literature)].
    Kovalenko AN
    Vrach Delo; 1983 Jan; (1):10-5. PubMed ID: 6223445
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coagulation and fibrinolysis in lung diseases (author's transl)].
    Tanaka K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Nov; 18(11):764-79. PubMed ID: 7289240
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathogenesis and pathologic physiology of disseminated intravascular coaguration (DIC) in patients with acute promyelocytic leukemia (author's transl)].
    Ando Y; Watanabe K
    Rinsho Ketsueki; 1976 Apr; 17(4):389-95. PubMed ID: 1066493
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination of high-performance affinity chromatography and specific detection of proenzyme applicable to the analysis of the fibrinolytic system of human plasma.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1987 Jan; 386():51-6. PubMed ID: 2951390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Symposium on the blood coagulation and fibrinolysis. (1) Pathophysiology of disseminated intravascular coagulation syndrome (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1975 Oct; 64(10):3-7. PubMed ID: 1238483
    [No Abstract]   [Full Text] [Related]  

  • 40. [TNP method (author's transl)].
    Igarashi M; Asada T; Urita Y; Shiba T; Matsumoto M
    Rinsho Byori; 1976 Apr; 24(4):308-11. PubMed ID: 132548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.